期刊文献+

3.0T磁共振动态增强及波谱成像对乳腺癌定性诊断的价值 被引量:15

The clinical values of 1H-MRS and DCE-MRI in diagnosing breast cancer
暂未订购
导出
摘要 目的探讨3.0T磁共振动态增强扫描(DCE-MRI)与氢质子波谱(1H-MRS)成像在乳腺癌定性诊断中的临床应用价值。方法收集我院经手术后病理或穿刺活检病理证实的乳腺肿瘤患者78例,共计82个肿瘤作为研究组,其中乳腺癌54个,良性肿瘤28个。全部病例均于术前行磁共振动态增强后1H-MRS检查,回顾性分析本组病例的DCE-MRI及1H-MRS表现,并将MRI诊断结果与病理结果进行对比分析。统计学处理采用χ2检验等。结果 DCE-MRI检查单独诊断乳腺癌的敏感性为87%,特异性为71%,准确性为82%,阳性预测值为86%,阴性预测值为74%。1H-MRS检查单独诊断乳腺癌的敏感性为91%,特异性为86%,准确性为89%,阳性预测值为92%,阴性预测值为83%。DCE-MRI联合1H-MRS诊断乳腺癌的敏感性为98%,特异性为82%,准确性为93%。结论磁共振波谱与动态增强扫描单独诊断乳腺癌的敏感性及准确率较低,二者联合应用可明显提高其敏感性和诊断准确率,对乳腺癌的术前定性诊断有重要应用价值。 Objective To evaluate the clinical values of 1H-MRS and DCE-magnetic resonance imaging (MRI) with 3.0T MRI system in the diagnosis of breast cancer. Methods Retrospective analysis on 82 breast tumors (54 malignant and 28 benign tumor) which were confirmed by pathological results. Study the features of 1H-MRS and DCE-MRI,and the results of 1H-MRS and DCE-MRI were compared with the pathology respectively. Chi-square test was adopted for statistics processing. Results The sensitivity, specificity , accuracy, positive predictive value and negative predictive value of time-signal intensity curve in diagnosing breast cancer were 87%, 71%, 82%, 86% and 74% respectively.While the sensitivity, specificity , accuracy, positive predictive value and negative predictive value of 1H-MRS in diagnosing breast cancer were 91%, 86%, 89%, 92%and 83%respectively. And the sensitivity, speci-ficity and accuracy of 1H-MRS associated with DCE-MRI in diagnosing breast cancer were 98%, 82%and 93%. Con-clusion The sensitivity is lower by only using 1H-MRS or DCE-MRI than that using 1H-MRS associated with DCE-MRI in diagnosing breast cancer. 1H-MRS associated with DCE-MRI is useful in qualitative diagnosis of breast cancer.
作者 李洪松
出处 《实用医学影像杂志》 2014年第1期22-24,共3页 Journal of Practical Medical Imaging
关键词 磁共振成像 磁共振波谱学 乳腺肿瘤 Magnetic resonance imaging Magnetic resonance spectroscopy Breast neoplasms
  • 相关文献

参考文献8

  • 1Morse DL,Carroll D,Day S. Characterization of breast can-cers and therapy response by MRS and quantitative gene expres-sion profiling in the choline pathway[J].{H}NMR IN BIOMEDICINE,2009.114-127.
  • 2Knutson D,Steiner E. Screening for breast cancer:current rec-ommendations and future directions[J].{H}American Family Physician,2007.1660-1666.
  • 3Helbbich TH. Contrast enhanced magnetic imaging resonance of the breast[J].{H}EUROPEAN JOURNAL OF RADIOLOGY,2000,(03):208-219.
  • 4高佩红;赵斌;蔡世峰.乳腺肿块动态增强及高分辩MRI表现与病理相关性研究[J]{H}医学影像学杂志,2006(09):667-661.
  • 5沈玉英,蔡庆,许传虓,顾培华,徐建良,黄振健,施增儒.动态增强MRI在乳腺疾病良恶性鉴别诊断中的价值[J].中国医学影像技术,2006,22(11):1678-1681. 被引量:24
  • 6Bartella L,Morris EA,Dershaw DD. Proton MR spec-troscopy with choline peak as malignancy marker improves posi-tive predictive value for breast cancer diagnosis:preliminary study[J].{H}RADIOLOGY,2006.686-692.
  • 7赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 8Huang W,Fisher PR,Dulaimy K. Detection of breast malig-nancy:diagnostic MR protocol for improved specificity[J].Radi-ology,2004.586-591.

二级参考文献22

  • 1Sinha S,Lucas-Quesada FA,DeBruhl ND,et al.Multifeature analysis of Gd-enhanced MR images of breast lesions.J Magn Reson Imaging,1997,7:1016-1026.
  • 2Kuhl CK,Mielcareck P,Klaschik S,et al.Dynamic breast MR imaging:are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology,1999,211:101-110.
  • 3Brinck U,Fischer U,Korabiowska M,et al.The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.AJR,1997,168:1331-1334.
  • 4Negendank W.Studies of human tumors by MRS:a review (Review).NMR Biomed,1992,5:303-324.
  • 5Cecil KM,Schnall MD,Siegelman ES,et al.The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.Breast Cancer Res Treat,2001,68:45-54.
  • 6Katz-Brull R,Lavin PT,Lenkinski RE.Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions(Review).J Natl Cancer Inst,2002,94:1197-1203.
  • 7Kvistad KA,Bakken IJ,Gribbestad IS,et al.Characterization of neoplastic and normal human breast tissues with in vivo 1H-MR spectroscopy.J Magn Reson Imaging,1999,10:159-164.
  • 8Roebuck JR,Cecil KM,Schnall MD,et al.Human breast lesions:characterization with proton MR spectroscopy.Radiology,1998,209:269-275.
  • 9Mackinnon WB,Barry PA,Malycha PL,et al.Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology,1997,204:661-666.
  • 10Jagannathan NR,Seenu V,Kumar M.Potential of in Vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent.Radiology,2002,223:281-282.

共引文献53

同被引文献111

  • 1王少华,赵瑞峰.磁共振成像诊断乳腺癌的研究进展[J].现代医用影像学,2012,21(1):8-11. 被引量:4
  • 2赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 3刘万花,邓钢,滕皋军,张琳琴,朱新丽,曹恒毅,黄璐,张园,何杰,张亚男.全数字化乳腺摄影与磁共振成像对乳腺癌诊断价值的比较[J].中国医学影像技术,2006,22(12):1819-1822. 被引量:16
  • 4Penny Whiting,Anne WS Rutjes,Johannes B Reitsma,Patrick MM Bossuyt,Jos Kleijnen,刁骧(译),艾昌林(译),秦莉(审校),姚巡(审校).QUADAS的制定:用于系统评价中评价诊断性研究质量的工具[J].中国循证医学杂志,2007,7(4):296-306. 被引量:68
  • 5郭志旺.氢质子磁共振波谱在颅内胶质瘤中的临床应用[D].南方医科大学2009
  • 6张照涛.14.7T核磁共振波谱评价脑胶质瘤细胞放射敏感性及放疗前后代谢物改变[D].山东大学2014
  • 7肖翔.~1H-MRS成像及PET/CT成像在颞叶癫痫术前定位中的应用研究[D].南方医科大学2014
  • 8Kuhl CK, Mielcareck P, Klaschik S, et ah Dynamic breast MR imaging: are signal intensity time course data useful for differential diag nosis of enhancing lesions[J] Radiology. 1999 . 211 : 101 -- 110.
  • 9Naveen S. Vasudev, Andrew R, et al. Anti angiogenic therapy for cancer: current progress, unresolved questions and future directions [J]. 2014,17(3):471-494.
  • 10Savannah C. Partridge, Karen M. Stone, et al. Breast DCE-MRI: Influence of post-contrast timing on automated lesion kinetics assess- ments and discrimination of benign and malignant lesions[J]. Acad Radiol,2014,21(9) :1195--1203.

引证文献15

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部